References
- Wajcman H, Blouquit Y, Gombaud-Saintonge G, et al. Hb Fontainebleau [α21(B2)Ala → Pro], a new silent mutant hemoglobin. Hemoglobin. 1989;13(5):421–428
- Almeida A, Henthorn JS, Davis S. Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region. Br J Haematol. 2001;112(1):32–35
- Upadhye DS, Jain D, Nair SB, et al. First case of Hb Fontainebleau with sickle haemoglobin and other nondeletional α-gene variants identified in neonates during newborn screening for sickle cell disorders. J Clin Pathol. 2012;65(7):654–659
- Kyrri AR, Felekis X, Kalogerou E, et al. Hemoglobin variants in Cyprus. Hemoglobin. 2009;33(2):81–94
- Brennan SO, Chan T, Ryken S, Ruskova A. A second case of Hb Fontainebleau [α21(B2)Ala → Pro] in an individual with microcytosis. Hemoglobin. 2009;33(3–4):258–261
- Mo Z-P, Yu C-S, Li Y-J, et al. Detection of α-globin gene deletion and duplication using quantitative multiplex PCR of short fluorescent fragments. Clin Chem Lab Med. 2012;50(4):649–654
- Thein SL, Wallace RB, Pressley L, et al. The polyadenylation site mutation in the α globin gene cluster. Blood. 2005;71(2):313–319